Sakar Healthcare Share Price

₹ 931.10

-₹13.70 (-1.45%)
1D
Last updated 02 Nov, 2026, 15:29 IST
NSE: SAKAR
|
Pharmaceuticals

Sakar Healthcare Share Price Today

As of 2 Nov 2026, Sakar Healthcare share price is ₹931.10. The stock opened at ₹930.10, compared to its previous close of ₹944.80. During today's trading session, Sakar Healthcare share price moved in the range of ₹908.15 to ₹958.00, with an average price of ₹933.08 for the day. Looking at its last 52-week, the stock has touched a low of ₹352.20 and a high of ₹1,229.85. On the performance front, Sakar Healthcare share price has increased by 50.43% over the last six months and is up 161.25% on a year-on-year basis.

Share price over the last 1 day rose from 926.90 to 931.10, ranging between 912.85 and 955.05.

₹908.15
1.45% down today
₹958.00
1D LOW
1D HIGH

Sakar Healthcare Stock Insights

Latest Earning
Op Profit TrendUp by 9.88% QoQ
Latest Earning
Net Profit TrendUp by 10.02% QoQ
Latest Earning
Revenue TrendUp by 17.70% QoQ
Stock Performance
OutperformingBeat Nifty by 12.19 % in last 3 month
Shareholding Pattern
PromoterPromoter decreased stake by 1.55%
Shareholding Pattern
DIIDII increased stake by 4.80%
Shareholding Pattern
FIIFII increased stake by 1.68%
Sakar Healthcare stock performance
Open₹930.10
High₹958.00
Low₹908.15
Prev. close₹944.80
Sakar Healthcare trading activity
Volume54,426
Average traded price₹931.32
Last traded time03:29:55 02 Nov
Last traded quantity7

Circuit
L
H
₹755.85
₹1,133.75
52-week
L
H
₹352.20
₹1,229.85
Mkt Cap Cr
2,102.17

P/E
49.03

P/B
6.08

ROA
8.31%
ROE
12.39%

ROCE
17.21%

Quick Ratio
0.64

EV/EBITDA
23.11

Based on fundamentals, this stock's

Performance: 1 out of 5, Very Poor
Performance
Very Poor
Sakar Healthcare has not beaten FD return of 7%
Valuation: 1 out of 5, Overvalued
Valuation
Overvalued
Sakar Healthcare appears overvalued compared to its peers
Earnings: 5 out of 5, Excellent
Earnings
Excellent
Sakar Healthcare revenue, operating profit and net profit are growing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROAROEROCEQuick RatioEV/EBITDA
Sun Pharmaceutical Industries4,26,661.7438.834.789.61%13.79%18.65%2.3122.27
Divis Laboratories2,57,902.7388.1715.3914.6%15.32%19.56%3.558.97
Torrent Pharmaceuticals1,76,306.2184.09.64.7%11.42%11.37%0.7533.6
Laurus Labs1,29,242.6897.021.3311.58%22.11%20.91%0.6854.77
Zydus Lifesciences1,24,089.4827.024.588.57%18.59%17.35%0.9116.42
Dr. Reddy's Laboratories1,12,698.5340.842.94.79%7.21%8.58%1.3519.05
Cipla1,11,486.1439.063.156.6%8.18%10.8%2.521.03
Mankind Pharma1,02,796.6045.425.857.82%12.76%14.68%0.7425.01
Aurobindo Pharma96,536.9026.022.556.34%9.25%11.76%1.1512.38
Lupin91,870.1616.554.0914.47%23.76%24.88%1.429.83

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

Sakar Healthcare Company Background

ISIN
INE732S01012
Sector Market Cap
₹ 2,102.17 Cr

Sakar Healthcare Limited is an India-based pharmaceutical company. The Company is engaged in manufacturing of pharmaceutical products providing liquid orals, cephalosporin tablets, capsules, dry powder syrup, dry powder injections, liquid injectables (SVP) in ampoules and vials & lyophilized injections. The Company's oncology products include oral solid dosage (tablet & capsule), liquid injection, lyophilized injection, active pharmaceutical ingredient (API), CDMO products and CRAMs. It has a presence across the regions of Africa (Anglo & Francophone), SEASIA, CIS, Latin & Central America and in Europe. It operates in over 50 countries globally and has approximately 292 registered products. It exports to Southeast Asia, Asia, Africa-Anglo & Francophone, MENA, America, covering around 38 countries with more than 250 brands registered.

Sakar Healthcare Financial Highlights

  • Revenue: Sakar Healthcare reported revenue of ₹254.03 crore in FY26 vs ₹178.89 crore in FY25. It showed an increase of 42.00% on a yearly basis.
  • Operating Profit: Sakar Healthcare reported an operating profit of ₹39.76 crore in FY26 vs ₹21.53 crore in FY25. It showed an increase of 84.67% on a year-on-year basis.
  • Net Profit: Sakar Healthcare reported a net profit of ₹30.48 crore in FY26 vs ₹17.50 crore in FY25. It showed an increase of 74.17% on a yearly basis.

Sakar Healthcare Quarterly Result Highlights

  • Sakar Healthcare reported revenue of ₹87.70 crore in Sep 2026, compared with ₹74.51 crore in Jun 2026, representing an increase of 17.70% on a quarter-on-quarter (QoQ) basis.
  • Sakar Healthcare reported an operating profit of ₹16.02 crore in Sep 2026, compared with ₹14.58 crore in Jun 2026, representing an increase of 9.88% on a quarter-on-quarter (QoQ) basis.
  • Sakar Healthcare reported a profit of ₹11.31 crore in Sep 2026, compared with ₹10.28 crore in Jun 2026, reflecting an increase of 10.02% on a QoQ basis.
  • The earnings per share (EPS) of Sakar Healthcare stood at ₹13.70 during Sep 2026.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Promoters
51.70%
FII
12.34%
Other DII
11.92%
Retail and other
24.04%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Dec 202513.05%
Mar 202612.94%
Jun 202612.14%
Sep 202612.34%

Sakar Healthcare Investment Returns

1 day
-0.18%

1 week
+6.18%

1 month
-13.56%

1 year
+161.25%

3 years
+182.45%

5 years
+516.11%

Sakar Healthcare Share Price History

Sakar Healthcare share price history by day, showing open and close prices and the percentage change
Day
Open / Close
Change %
30 Oct 26
₹947.00 / ₹944.80
-0.18%
29 Oct 26
₹980.20 / ₹946.50
-4.30%
28 Oct 26
₹930.30 / ₹989.00
+6.31%
27 Oct 26
₹979.00 / ₹930.30
-4.17%
Show more

Sakar Healthcare Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹251.74₹177.58₹153.35₹133.36
Other Income₹2.29₹1.31₹3.18₹4.67
Total Revenue₹254.02₹178.90₹156.53₹138.03
Total Expenses₹214.27₹157.32₹140.63₹121.15
Profit Before Tax₹39.76₹21.53₹15.90₹16.88
Tax₹9.27₹4.03₹4.23₹4.12
Profit After Tax₹30.48₹17.50₹11.67₹12.76
EPS - Basic₹13.70₹7.97₹5.63₹6.75
EPS - Diluted₹13.70₹7.95₹5.63₹6.75

Cash Flow · Consolidated

Cash Flow · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹39.76₹21.53₹15.90₹16.88
Income before WC changes₹70.56₹50.49₹40.80₹37.01
Change in Assets-₹61.05-₹17.29-₹18.76-₹9.01
Change in Liabilities₹43.75₹3.21₹119.78₹9.60
Change in WC-₹17.29-₹14.08₹101.03₹0.60
Cash flow from Operations₹49.26₹34.03₹24.47₹33.34
Cash flow from Investing-₹28.35-₹30.71-₹51.54-₹74.38
Cash flow from Financing-₹20.96-₹3.48₹27.44₹41.10
Total Cash Flow-₹0.05-₹0.16₹0.37₹0.06
Cash (Start of the year)₹0.31₹0.47₹0.09₹0.03
Cash (End of the year)₹0.26₹0.31₹0.47₹0.09

Balance Sheet · Consolidated

Balance Sheet · Consolidated — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹340.55₹326.53₹317.05₹280.42
Current Assets₹140.46₹88.73₹71.61₹55.92
Total Assets₹481.01₹415.26₹388.66₹336.34
Current Liabilities₹109.54₹63.19₹59.06₹54.49
Net Current Asset₹30.92₹25.54₹12.55₹1.42
Non-Current Liabilities₹47.02₹66.60₹67.27₹108.50
Equity Capital₹324.45₹285.48₹262.33₹173.35
Total Equity & Liabilities₹481.01₹415.26₹388.66₹336.34

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹251.74₹177.58₹153.35₹133.36
Other Income₹2.29₹1.31₹3.18₹4.67
Total Revenue₹254.02₹178.90₹156.53₹138.03
Total Expenses₹214.27₹157.32₹140.63₹121.15
Profit Before Tax₹39.76₹21.53₹15.90₹16.88
Tax₹9.27₹4.03₹4.23₹4.12
Profit After Tax₹30.48₹17.50₹11.67₹12.76
EPS - Basic₹13.70₹7.97₹5.64₹6.75
EPS - Diluted₹13.70₹7.95₹5.63₹6.75

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹39.76₹21.53₹15.90₹16.88
Income before WC changes₹70.56₹50.49₹40.80₹37.01
Change in Assets-₹61.05-₹17.29-₹18.76-₹9.01
Change in Liabilities₹43.75₹3.21₹5.57₹9.60
Change in WC-₹17.29-₹14.08-₹13.18₹0.60
Cash flow from Operations₹49.26₹34.03₹24.47₹33.34
Cash flow from Investing-₹28.35-₹30.71-₹51.54-₹74.38
Cash flow from Financing-₹20.96-₹3.48₹27.44₹41.10
Total Cash Flow-₹0.05-₹0.16₹0.37₹0.06
Cash (Start of the year)₹0.31₹0.46₹0.09₹0.03
Cash (End of the year)₹0.26₹0.31₹0.46₹0.09

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹340.56₹326.54₹317.06₹280.43
Current Assets₹140.53₹88.80₹71.69₹55.99
Total Assets₹481.09₹415.35₹388.74₹336.42
Current Liabilities₹109.54₹63.19₹59.06₹54.49
Net Current Asset₹31.00₹25.62₹12.63₹1.50
Non-Current Liabilities₹47.02₹66.60₹67.27₹108.50
Equity Capital₹324.54₹285.56₹262.42₹173.43
Total Equity & Liabilities₹481.09₹415.35₹388.74₹336.42
* All values are in INR Crore
Sakar Healthcare market depth
Bid quantityBid priceAsk priceAsk quantity
0000
0000
0000
0000
0000
Total bid quantity0
Total ask quantity0
Sakar Healthcare technical summary
Bearish indicators2
Neutral indicators6
Bullish indicators0
OverallSlightly Bearish
by SEBI experts

Expert Pick

EXPPICK
Stop-loss
Stop-loss is locked. Sign in to view.
Entry price
Entry price is locked. Sign in to view.
Target
Target is locked. Sign in to view.
Indicator
Value
Verdict

RSI (14)
45.53
Neutral

ATR (14)
78.29
Neutral

STOCH(9,6)
54.56
Neutral

STOCH RSI (14)
69.86
Neutral

ADX(9)
24.58
Bearish

UO(9)
46.88
Neutral

ROC(12)
-0.71
Bearish

WillR(14)
-50.06
Neutral
Period
Simple value
Exponential vaue

5D
956.28
949.79

10D
941.27
955.39

20D
976.02
978.23

50D
1016.09
985.17

100D
935.9
923.66
Volume trend — traded volume by day
2 Nov0L
30 Oct1L
29 Oct1L
28 Oct2L
27 Oct1L
26 Oct2L
Average1L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks

Sakar Healthcare
Pharmaceuticals
Add Stock
Add Another

Sakar Healthcare Returns Calculator

Sakar Healthcare Share Price FAQs












Please be aware that Sakar Healthcare stock prices are subject to continuous fluctuations due to various factors.